Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket

Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading.

Gainers

  • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) shares rose 85.8% to $0.7985 in pre-market trading.
  • Chijet Motor Company, Inc. (NASDAQ:TTOO) shares surged 51.3% to $0.1060 in pre-market trading after dipping around 31% on Monday. T2 Biosystems reported submission for the FDA breakthrough device designation for candida auris diagnostic test.
  • Secoo Holding Limited (NASDAQ:SECO) gained 35.8% to $1.100 in pre-market trading.
  • Zura Bio Limited (NASDAQ:ZURA) shares gained 35.4% to $8.79 in pre-market trading after the company completed approximately $80 million financing with the focus on advancing ZB-106, a potential first-in-class anti-IL-17 and anti-BAFF dual antagonist.
  • Greenlane Holdings, Inc. (NASDAQ:GNLN) gained 29.5% to $0.36 in pre-market trading. Greenlane reported effectiveness of previously announced reverse stock split.
  • GitLab Inc. (NASDAQ:GTLB) shares rose 27.6% to $45.18 in pre-market trading following better-than-expected first-quarter results.
  • Regional Health Properties, Inc. (NYSE:RHE) shares climbed 25.8% to $3.78 in pre-market trading after gaining around 4% on Monday.
  • Mereo BioPharma Group plc – ADR (NASDAQ:MREO) rose 16.2% to $1.22 in pre-market trading. Ultragenyx and Mereo BioPharma reported data from ongoing Phase 2/3 Orbit study of Setrusumab (UX143) in Osteogenesis Imperfecta (OI).
  • Bioventus Inc. (NASDAQ:BVS) rose 16% to $3.13 in pre-market trading after declining around 9% on Monday.
  • Coya Therapeutics, Inc. (NASDAQ:COYA) shares gained 13.5% to $4.77 in pre-market trading after declining 8% on Monday.

Losers

  • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) fell 39.6% to $1.01 in pre-market after dropping over 20% on Monday.
  • Pasithea Therapeutics Corp (NASDAQ:KTTA) shares dropped 35% to $0.33 in pre-market trading. Pasithea Therapeutics shares jumped 25% on Monday after Lucy Scientific Discovery proposed to acquire the company for $0.60 per share in cash and $0.25 per share in Lucy stock.
  • Sono Group N.V. (NASDAQ:SEV) fell 15.7% to $0.2569 in pre-market trading after gaining around 76% on Monday.
  • View, Inc. (NASDAQ:VIEW) fell 13.5% to $0.1685 in pre-market trading. View announced plans for reverse stock split to ensure full compliance with Nasdaq listing rules.
  • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) fell 12.2% to $0.2002 in pre-market trading. Bluejay Diagnostics filed for mixed shelf of up to $25 million.
  • Ucommune International Ltd (NASDAQ:UK) shares dropped 11.5% to $0.8935 in pre-market trading after surging over 50% on Monday.
  • AgriFORCE Growing Systems Ltd (NASDAQ:AGRI) fell 10.6% to $0.17 in pre-market trading after dropping 44% on Monday.
  • Ayro, Inc. (NASDAQ:AYRO) shares fell 10% to $0.50 in pre-market trading. AYRO, last month, reported a first-quarter sales decline of 89% Y/Y to $0.113 million, missing the consensus of $0.300 million.
  • ACM Research, Inc. (NASDAQ:ACMR) fell 8.5% to $8.90 in pre-market trading.
  • Timber Pharmaceuticals, Inc. (NYSE:TMBR) fell 8.5% to $1.72 in pre-market trading. Timber Pharmaceuticals shares jumped 26% on Monday following a positive decision from the FDA for its TMB-001 treatment.

 

Now Read This: Dow Drops 200 Points But Investor Sentiment Improves

Total
0
Shares
Related Posts
Read More

AstraZeneca Unit Alexion Said Aims to Advance NMOSD Treatment Landscape with Exceptional Ultomiris Efficacy data at ECTRIMS 2022

Alexion, AstraZeneca Rare Disease, will present new data showing significant advances for the treatment of anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD) at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, 26 to 28 October 2022.

AZN